Related Experiment Videos

Clinical experience with the Björk-Shiley Delrin tilting disc heart valve

K C Dellsperger1, G L Grunkemeier, P D Stein

  • 1University of Iowa, Department of Internal Medicine, Iowa City, USA.

Insights

Clinically important regurgitation from Björk-Shiley Delrin (BSD) disc heart valve wear is rare but possible. Larger BSD valves showed more wear, though disc fracture was not reported.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Surgery
  • Medical Device Engineering

Background:

  • The Björk-Shiley Delrin (BSD) disc heart valve was introduced clinically in 1969.
  • An estimated 7,000 patients were alive with a BSD valve as of January 1996.

Purpose of the Study:

  • To assess the long-term performance and potential complications of the Björk-Shiley Delrin disc heart valve.
  • To evaluate disc wear, regurgitation, and structural integrity of explanted BSD valves.

Main Methods:

  • Review of published clinical experience with BSD valves.
  • Analysis of explanted BSD valve records from Shiley Incorporated.
  • Measurement of disc wear, including radial gap and static leak flow rate.

Main Results:

  • Clinically significant regurgitation due to disc wear was infrequent.
  • Larger valve sizes exhibited more pronounced disc wear compared to smaller ones.
  • No Delrin disc fractures were reported; however, two cases of inlet strut fracture occurred.

Conclusions:

  • Disc wear in BSD valves rarely leads to clinically important regurgitation.
  • While disc fracture is absent, inlet strut fractures and late disc embolization are potential risks.
  • Disc wear does not typically impede normal valve function but can increase regurgitation.
Abstract

Related Concept Videos